Association between SGLT-2 inhibitors and suicide risk in type 2 diabetes and bipolar: a real-world cohort study
BackgroundIndividuals with bipolar disorder face a significantly elevated suicide risk, and comorbid type 2 diabetes mellitus (T2DM) further complicates their psychiatric and medical outcomes. Sodium–glucose co-transporter-2 inhibitors (SGLT-2i) have demonstrated cardiometabolic benefits in T2DM, bu...
Saved in:
| Main Authors: | En-Wei Chang, Jing-Yang Huang, Shih-Chang Lo, Chien-Ning Huang, Yi-Sun Yang, Edy Kornelius |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1601118/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between bipolar disorder and diabetic ketoacidosis/hyperosmolar hyperglycemic state
by: Han-Jung Liu, et al.
Published: (2025-07-01) -
Anxiety disorders in patients with thyroid nodules vs. thyroid cancer: a retrospective cohort study
by: Edy Kornelius, et al.
Published: (2025-04-01) -
Association of herpes zoster vaccination and cardiovascular risk in patients with diabetes: long-term insights from a retrospective cohort study
by: Yu-Hsun Wang, et al.
Published: (2025-02-01) -
SGLT2 inhibitors reduce the risk of renal failure in CKD stage 5 patients with Type 2 DM
by: Birdie Huang, et al.
Published: (2025-02-01) -
Sodium-glucose cotransporter 2 Inhibitors and COVID-19 outcomes in type 2 diabetes patients: A population-based cohort study
by: Cerina Dubois, et al.
Published: (2025-07-01)